This information is provided for reference purposes only and does not constitute advertising, an offer, a public offering, or a user manual. It is presented solely for the information of our patients abroad. This website does not engage in any form of distance selling. The sale, distribution, delivery, or prescription of products is not permitted through this website. Products and medical services may only be used as prescribed by a physician. Consultations are provided by clinic specialists in person or via remote medical consultations within the framework of current legislation. Please note that this directory does not programmatically permit the sale of products.
Diagnosis of целиакия
Analyses:
Genetic Testing: HLA-DQ2 and HLA-DQ8
Antibodies to Tissue Transglutaminase (tTG-IgA)
Antibodies to Deamidated Gliadin Peptide (DGP-IgA and DGP-IgG)
Antibodies to Endomysium (EMA-IgA, IgG)
Celiac disease is a chronic autoimmune disorder associated with gluten intolerance. Its diagnosis involves genetic tests (HLA-DQ2 and DQ8) and the detection of specific antibodies: to tissue transglutaminase, deamidated gliadin peptide, and endomysium. These tests help confirm or exclude celiac disease, assess the risk of its development in relatives, and monitor adherence to a gluten-free diet in patients.
Genetic Testing: HLA-DQ2 and HLA-DQ8
Antibodies to Tissue Transglutaminase (tTG-IgA)
Antibodies to Deamidated Gliadin Peptide (DGP-IgA and DGP-IgG)
Antibodies to Endomysium (EMA-IgA, IgG)
Celiac disease is a chronic autoimmune disorder associated with gluten intolerance. Its diagnosis involves genetic tests (HLA-DQ2 and DQ8) and the detection of specific antibodies: to tissue transglutaminase, deamidated gliadin peptide, and endomysium. These tests help confirm or exclude celiac disease, assess the risk of its development in relatives, and monitor adherence to a gluten-free diet in patients.
